163 related articles for article (PubMed ID: 26844860)
41. Genetic testing in cardiovascular medicine: current landscape and future horizons.
Sturm AC; Hershberger RE
Curr Opin Cardiol; 2013 May; 28(3):317-25. PubMed ID: 23571470
[TBL] [Abstract][Full Text] [Related]
42. Best practices: antenatal screening for common genetic conditions other than aneuploidy.
Ram KT; Klugman SD
Curr Opin Obstet Gynecol; 2010 Apr; 22(2):139-45. PubMed ID: 20125016
[TBL] [Abstract][Full Text] [Related]
43. Medical-ethical guidelines for genetic investigations in humans.
Müller HJ; Deonna T; Abbt I; Bachmann C; Bär W; Brückner Ch; Bühler E; Courvoisier B; Dayer P; Fuchs E; Gelzer J; Guillod O; Gutzwiller F; Heierli C; Hitzig W; Moser H; Möhr-Baumann E; Pescia G; Sitter-Liver B; Thévoz JM; Waldboth Y; Weber W; Wicki S
Schweiz Med Wochenschr; 1994 Jun; 124(22):974-9. PubMed ID: 11644551
[No Abstract] [Full Text] [Related]
44. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
[TBL] [Abstract][Full Text] [Related]
45. Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors.
McKinnon WC; Baty BJ; Bennett RL; Magee M; Neufeld-Kaiser WA; Peters KF; Sawyer JC; Schneider KA
JAMA; 1997 Oct; 278(15):1217-20. PubMed ID: 9333247
[No Abstract] [Full Text] [Related]
46. Clinically Actionable Findings Derived From Predictive Genomic Testing Offered in a Medical Practice Setting.
Anderson JL; Kruisselbrink TM; Lisi EC; Hughes TM; Steyermark JM; Winkler EM; Berg CM; Vierkant RA; Gupta R; Ali AH; Faubion SS; Aoudia SL; McAllister TM; Farrugia G; Stewart AK; Lazaridis KN
Mayo Clin Proc; 2021 Jun; 96(6):1407-1417. PubMed ID: 33890576
[TBL] [Abstract][Full Text] [Related]
47. Targeted carrier screening for four recessive disorders: high detection rate within a founder population.
Mathijssen IB; Henneman L; van Eeten-Nijman JM; Lakeman P; Ottenheim CP; Redeker EJ; Ottenhof W; Meijers-Heijboer H; van Maarle MC
Eur J Med Genet; 2015 Mar; 58(3):123-8. PubMed ID: 25641760
[TBL] [Abstract][Full Text] [Related]
48. A next generation sequencing test.
Levenson D
Am J Med Genet A; 2011 Jul; 155A(7):x-xi. PubMed ID: 21698767
[No Abstract] [Full Text] [Related]
49. Strategies and logistical requirements for efficient testing in genetic disease.
Jackson-Cook C; Pandya A
Clin Lab Med; 1995 Dec; 15(4):839-57. PubMed ID: 8838226
[TBL] [Abstract][Full Text] [Related]
50. Screening for single gene genetic disease.
Musci TJ
Gynecol Obstet Invest; 2005; 60(1):19-26. PubMed ID: 15731563
[TBL] [Abstract][Full Text] [Related]
51. From genetics to genomics: ethics, policy, and parental decision-making.
Wilfond B; Ross LF
J Pediatr Psychol; 2009 Jul; 34(6):639-47. PubMed ID: 18647793
[TBL] [Abstract][Full Text] [Related]
52. Current practice and attitudes of Australian obstetricians toward population-based carrier screening for inherited conditions.
Stark Z; Massie J; McClaren B; Ioannou L; Cousens N; Lewis S; Metcalfe S; Delatycki MB
Twin Res Hum Genet; 2013 Apr; 16(2):601-7. PubMed ID: 23331496
[TBL] [Abstract][Full Text] [Related]
53. Expanded carrier screening for monogenic disorders: where are we now?
Chokoshvili D; Vears D; Borry P
Prenat Diagn; 2018 Jan; 38(1):59-66. PubMed ID: 28685505
[TBL] [Abstract][Full Text] [Related]
54. Disclosure of genetic information obtained through research.
Quaid KA; Jessup NM; Meslin EM
Genet Test; 2004; 8(3):347-55. PubMed ID: 15727261
[TBL] [Abstract][Full Text] [Related]
55. [Carrier testing].
Kawame H
Nihon Rinsho; 2005 Dec; 63 Suppl 12():99-103. PubMed ID: 16416778
[No Abstract] [Full Text] [Related]
56. Contemporary genetic counseling.
Edwards JG
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):1-9, Table of Contents. PubMed ID: 20494253
[TBL] [Abstract][Full Text] [Related]
57. Community knowledge about human genetics.
Decruyenaere M; Evers-Kiebooms G; Van den Berghe H
Birth Defects Orig Artic Ser; 1992; 28(1):167-84. PubMed ID: 1340227
[No Abstract] [Full Text] [Related]
58. Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.
Chokoshvili D; Vears DF; Borry P
Best Pract Res Clin Obstet Gynaecol; 2017 Oct; 44():57-67. PubMed ID: 28302443
[TBL] [Abstract][Full Text] [Related]
59. Genetic Testing: Consent and Result Disclosure for Primary Care Providers.
Faucett WA; Peay H; Coughlin CR
Med Clin North Am; 2019 Nov; 103(6):967-976. PubMed ID: 31582007
[TBL] [Abstract][Full Text] [Related]
60. Cystic fibrosis carrier screening practices in an ethnically diverse region: experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands.
Schwind EL; Wolfe M; Greendale K; Misra LM; Pass KA; Wallerstein R
Genet Test; 1999; 3(2):215-8. PubMed ID: 10464670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
